RPS3	RPS3 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis initiation. It belongs to the S3P family and has an extraribosomal role in UV-induced DNA damage repair. Located in cytoplasm and nucleus, its expression is higher in colon adenocarcinomas. Co-transcribed with U15A and U15B snoRNAs, it has multiple pseudogenes and spliced variants.
IGLL5	IGLL5 is part of the immunoglobulin lambda locus, encoding polypeptides without somatic rearrangement. The gene's first exon is unrelated to immunoglobulin variable genes; subsequent exons are immunoglobulin lambda segments. Alternative splicing leads to multiple transcript variants. Its expression and variants may be associated with breast cancer.
RPLP1	RPLP1 encodes a ribosomal phosphoprotein in the 60S subunit, part of the L12P family, involved in protein synthesis elongation. It is acidic and forms a pentameric complex with P0 and P2. Located in the cytoplasm, it has two transcript variants and multiple pseudogenes. Linked to breast cancer studies.
TFF3	TFF3 is a trefoil family member with a trefoil motif, secreted in gastrointestinal mucosa. It may protect mucosa, stabilize mucus, and aid epithelial healing. TFF3 is expressed in goblet cells of intestines and colon. Located on chromosome 21, it is linked to breast cancer via expression regulation in cancerous tissues.
RPS18	RPS18 encodes a ribosomal protein in the 40S subunit, part of the ribosome involved in protein synthesis. It belongs to the S13P family, located in the cytoplasm, and is linked to the initiation of translation. The gene has multiple pseudogenes in the genome and is related to breast cancer pathology.
GAPDH	GAPDH encodes glyceraldehyde-3-phosphate dehydrogenase, involved in carbohydrate metabolism. It performs multiple functions, including oxidative phosphorylation, uracil DNA glycosylase activity, and antimicrobial action. It also regulates mRNA stability and acts as a transferrin receptor. GAPDH is implicated in breast cancer pathogenesis. Alternative splicing generates multiple variants.
TMSB10	TMSB10 is linked to breast cancer. It facilitates actin monomer binding and influences cell migration. It sequesters actin monomers, operates in the cytoskeleton, and is active in the cytoplasm.
RPLP2	RPLP2 encodes a ribosomal phosphoprotein part of the 60S subunit, involved in protein synthesis elongation. It forms a complex with P0 and P1. Located in cytoplasm, it is acidic, unlike basic ribosomal proteins. RPLP2 has pseudogenes throughout the genome. Related to breast cancer, it may influence ribosome function and protein production, impacting cancer cell growth.
RPS14	RPS14 encodes a ribosomal protein part of the 40S subunit involved in protein synthesis. Located in the cytoplasm, it belongs to the S11P family. Multiple transcript variants exist. Mutations can cause emetine resistance in Chinese hamster ovary cells. Pseudogenes are dispersed in the genome. RPS14's role in breast cancer is under investigation.
RPL37A	RPL37A encodes a ribosomal protein in the 60S subunit, part of the L37AE family, located in the cytoplasm. It features a C4-type zinc finger-like domain. Ribosomal proteins like RPL37A have multiple pseudogenes. RPL37A's role in protein synthesis may influence breast cancer progression, as ribosome function is linked to cellular growth and proliferation.
RPS19	RPS19 encodes a ribosomal protein of the 40S subunit, located in cytoplasm. Mutations cause Diamond-Blackfan anemia. Possible extra-ribosomal roles in erythropoietic differentiation. Observed higher expression in primary colon carcinomas. Multiple pseudogenes dispersed in genome. Potential link to breast cancer due to protein synthesis involvement.
RPL28	RPL28 encodes a component of the 60S ribosomal subunit involved in protein synthesis. Located in cytoplasm, it belongs to L28E family. Expression varies in colorectal cancer; pseudogenes and transcript variants exist. No link to disease severity found. Related to breast cancer studies.
KRT19	KRT19 encodes a keratin protein in epithelial cells, part of the intermediate filament protein family. It is expressed in the periderm of developing epidermis. KRT19 is located on chromosome 17q12-q21. Its isolated expression pattern differs from other cytokeratins, as it is not paired with a basic keratin. KRT19 is associated with breast cancer, serving as a biomarker for tumor cells due to its epithelial origin.
RPL8	RPL8 encodes a ribosomal protein part of the 60S subunit involved in protein synthesis. It interacts with 5.8S rRNA and possibly participates in aminoacyl-tRNA binding and elongation factor 2-binding. Located in the cytoplasm, it has multiple processed pseudogenes. Associated with breast cancer, its mutations or expression changes may impact cell proliferation or protein synthesis.
RPL13	RPL13 encodes a ribosomal protein in the 60S subunit, part of the L13E family. Located in the cytoplasm, it shows higher expression in benign breast lesions than breast carcinomas. RPL13 has alternatively spliced variants and multiple pseudogenes. It plays a role in protein synthesis and is linked to breast cancer studies.
RPL19	RPL19 encodes a ribosomal protein in the 60S subunit, part of the L19E family. It is located in the cytoplasm and has multiple pseudogenes. Associated with ribosome function, RPL19 has implications in breast cancer through its role in protein synthesis.
ACTB	ACTB encodes actin proteins essential for cell motility, structure, and signaling. Mutations can lead to Baraitser-Winter syndrome 1, linked with intellectual disability and distinctive facial features. ACTB is expressed in breast cancer, playing a role in cytoskeletal functions and tumor progression. Numerous pseudogenes exist across the human genome.
RPL36	RPL36 encodes a ribosomal protein part of the 60S subunit, belonging to the L36E family, found in the cytoplasm. Alternative splicing creates transcript variants encoding the same protein. RPL36 has multiple pseudogenes across the genome. It may have implications in breast cancer due to its role in protein synthesis.
RPL18A	RPL18A encodes a ribosomal protein in the 60S subunit, involved in protein synthesis. It may interact with the hepatitis C virus IRES and is co-transcribed with U68 snoRNA. The gene has multiple pseudogenes.
RPL35	RPL35 encodes a ribosomal protein in the 60S subunit, part of the L29P family. Located in the cytoplasm, it contributes to protein synthesis. Associated with breast cancer, it has multiple pseudogenes across the genome.
RPL18	RPL18 encodes a ribosomal protein in the L18E family, part of the 60S subunit in ribosomes, involved in protein synthesis. It has processed pseudogenes and alternatively spliced transcript variants. RPL18 is associated with breast cancer development.
RPS2	RPS2 encodes a ribosomal protein in the 40S subunit, part of the S5P family, located in the cytoplasm. It is co-transcribed with snoRNA gene U64 in its third intron. RPS2 has processed pseudogenes throughout the genome. Linked to protein synthesis, RPS2 may have implications in breast cancer research due to its role in cellular growth and proliferation.
RPS12	RPS12 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. Located in the cytoplasm, RPS12 belongs to the S12E ribosomal protein family and shows increased expression in colorectal cancers. It has multiple processed pseudogenes throughout the genome. RPS12 may have implications in breast cancer due to its role in cellular protein synthesis and potential involvement in cancer-related pathways.
RPS21	RPS21 encodes a ribosomal protein in the 40S subunit, part of the S21E family. Located in cytoplasm, involved in protein synthesis. Multiple pseudogenes exist. Alternative splice variants reported but unverified. Ribosomal protein genes often have dispersed pseudogenes. Associated with breast cancer risk in humans.
RACK1	RACK1, involved in breast cancer, facilitates cyclin binding, enzyme binding, and protein domain specific binding. It regulates protein metabolism, signal transduction, and vesicle-mediated transport. Located in midbody, perinuclear cytoplasm, and phagocytic cup, it is part of the IRE1-RACK1-PP2A complex.
RPL13A	RPL13A encodes a ribosomal protein of the 60S subunit, involved in protein synthesis and inflammatory gene repression via the GAIT complex. It is co-transcribed with small nucleolar RNA genes U32, U33, U34, U35. Multiple pseudogenes exist across the genome, and alternative splicing produces various isoforms.
CTSD	CTSD gene encodes cathepsin D, a peptidase involved in protein turnover, hormone activation, and growth factor processing. Mutations are linked to neuronal ceroid lipofuscinosis-10 and implicated in breast cancer pathogenesis. It may also relate to Alzheimer's disease development.
FTL	FTL encodes the light subunit of ferritin, a key intracellular iron storage protein. Ferritin is composed of heavy and light chains, affecting iron uptake/release. FTL mutations are linked to neurodegenerative diseases and hyperferritinemia-cataract syndrome. It plays a role in iron storage in a soluble, nontoxic form and has multiple pseudogenes. FTL may influence breast cancer by altering iron metabolism.
PFN1	PFN1 encodes an actin-binding protein involved in actin polymerization regulation. It is linked with Miller-Dieker syndrome and may influence Huntington disease. PFN1 pseudogenes are on chromosome 1. In breast cancer, PFN1's role in cytoskeletal dynamics might affect cell migration and invasion, contributing to cancer progression.
MGP	MGP encodes a vitamin K-dependent protein secreted by chondrocytes and vascular smooth muscle cells, inhibiting ectopic tissue calcification. It is linked to vascular calcification in cardiovascular disease and synovial membrane calcification in osteoarthritis. Mutations cause Keutel syndrome, involving cartilage calcification, pulmonary stenosis, and facial hypoplasia. MGP's role in breast cancer is understudied, but its function in calcification regulation may be relevant.
RPS15	RPS15 encodes a ribosomal protein in the 40S subunit, linked to protein synthesis. It belongs to the S19P family, located in the cytoplasm. RPS15 is activated in tumors, including breast cancer, insulinomas, esophageal, and colon cancers. The gene has multiple pseudogenes and transcript variants due to alternative splicing.
RPS11	RPS11 encodes a ribosomal protein of the 40S subunit, belongs to S17P family, co-transcribed with small nucleolar RNA U35B. Involvement in protein synthesis, with multiple pseudogenes present. Associated with breast cancer.
RPS16	RPS16 encodes a ribosomal protein part of the 40S subunit in the cytoplasm, related to protein synthesis. It is linked to breast cancer and belongs to the S9P family. Multiple pseudogenes exist across the genome.
HLA-B	HLA-B is part of HLA class I molecules, composed of a heavy chain and beta-2 microglobulin. It presents peptides from the endoplasmic reticulum, expressed in most cells. The gene has 8 exons, with polymorphisms in exons 2 and 3 affecting peptide binding. Significant in immune function, and genetic typing is used in transplants. Associated with immune response in breast cancer.
UBA52	UBA52 codes for a fusion protein with ubiquitin and ribosomal protein L40. Ubiquitin targets proteins for degradation by the 26S proteosome, maintains chromatin structure, regulates gene expression, and responds to stress. UBA52 is linked to breast cancer through its role in protein degradation and regulation, which can affect cancer cell growth and gene expression. Multiple pseudogenes exist in the genome.
NHERF1	NHERF1 encodes a sodium/hydrogen exchanger regulatory cofactor involved in protein interaction and regulation. It affects cystic fibrosis transmembrane conductance regulator, G-protein coupled receptors like beta2-adrenergic receptor, and parathyroid hormone 1 receptor. NHERF1 links membrane and cytoskeletal proteins, localizing to actin-rich structures. Mutations lead to hypophosphatemic nephrolithiasis/osteoporosis type 2; loss of heterozygosity associates with breast cancer.
RPS17	RPS17 encodes a protein in the 40S ribosomal subunit, involved in protein synthesis. Located in the cytoplasm and part of the S17E ribosomal protein family. Mutations cause Diamond-Blackfan anemia 4. Alternative splicing leads to multiple transcripts. Contains pseudogenes in the genome. Associated with breast cancer studies.
PSAP	PSAP encodes prosaposin, involved in lipid metabolism and lysosomal storage. Though mainly linked to pulmonary functions, PSAP's overexpression may influence breast cancer progression through cellular signaling pathways. Research indicates potential interactions with growth factors and receptors in cancerous tissues. Splicing variants contribute to diverse functional roles. Studies suggest monitoring PSAP expression levels in breast cancer diagnostics and treatment strategies.
RPLP0	RPLP0 encodes a ribosomal protein of the 60S subunit, homologous to E. coli L10. It forms a pentameric complex with P1/P2, located in cytoplasm. Transcript variants exist via alternative splicing. Linked to breast cancer through altered protein synthesis and cell proliferation. Multiple pseudogenes distributed in genome.
SERF2	SERF2 is involved in protein destabilization, located in cytosol and nucleus. It may play a role in cellular processes related to breast cancer. Further research needed to clarify its specific mechanisms in cancer development.
RPS27	RPS27 encodes a protein of the 40S ribosomal subunit, contains a C4-type zinc finger domain, and potentially binds nucleic acids. Mutations are linked to melanoma and Diamond-Blackfan anemia. High expression is observed in several cancers, including breast cancer. Multiple pseudogenes exist throughout the genome.
RPS8	RPS8 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. Located in the cytoplasm, it shows increased expression in colorectal tumors. Co-transcribed with small nucleolar RNA genes U38A, U38B, U39, and U40. Multiple pseudogenes present. Studies suggest potential relevance to breast cancer.
RPL27A	RPL27A encodes a ribosomal protein part of the 60S subunit in the cytoplasm, member of the L15P family. It's variably expressed in cancers, including breast cancer, but not linked to disease severity. Multiple pseudogenes exist across the genome.
MUC1	MUC1 encodes a membrane-bound mucin protein involved in forming protective mucous barriers and intracellular signaling. It is expressed in epithelial cells of tissues like lung, breast, and pancreas. The protein is cleaved into alpha and beta subunits for cell adhesion and signaling. Overexpression and altered glycosylation are linked to carcinomas. MUC1 contains a polymorphic VNTR domain, with alternate splicing producing multiple variants.
RPS28	RPS28 encodes a ribosomal protein part of the 40S subunit, belonging to the S28E family, located in the cytoplasm. It has multiple pseudogenes across the genome. This gene is linked to protein synthesis and has been implicated in breast cancer.
H2AJ	H2AJ is a replication-independent histone variant located on chromosome 12, part of the nucleosome structure in eukaryotic chromosomal fiber. It features a divergent C-terminus compared to consensus H2A. H2AJ also encodes an antimicrobial peptide with antibacterial and antifungal activity, and is related to breast cancer in humans.
RPL10	RPL10 encodes a ribosomal protein in the 60S subunit. It interacts with c-Jun, affecting transcriptional activation. Variants are linked to autism spectrum disorders with mixed evidence. Multiple pseudogenes exist, and alternative splicing yields various transcripts. Implicated in breast cancer research.
CALR	CALR is a chaperone protein in the endoplasmic reticulum, involved in cell adhesion, protein folding, and calcium regulation. It appears in the nucleus, possibly affecting transcription. Mutations in CALR are linked to neoplasms, including breast cancer and systemic lupus erythematosus with autoantibody titers.
RPS29	RPS29 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. It has a C2-C2 zinc finger domain enhancing tumor suppressor activity in Ras-related protein 1A. Found in the cytoplasm, RPS29 shows variable expression in colorectal cancers. Multiple pseudogenes and alternatively spliced variants exist. Potential relevance in breast cancer due to its role in protein synthesis and cellular growth regulation.
RPL38	RPL38 encodes a ribosomal protein part of the 60S subunit involved in protein synthesis. It belongs to the L38E family and is cytoplasmic. Alternative splice variants encode the same protein. Multiple processed pseudogenes exist, one near the type 1 angiotensin II receptor gene, linked to breast cancer.
RPL11	RPL11 encodes a ribosomal protein in the 60S subunit, part of the L5P family, located in the cytoplasm. It interacts with 5S rRNA and has spliced transcript variants. Multiple pseudogenes exist. RPL11 is implicated in breast cancer through ribosome biogenesis disruption affecting cell proliferation.
P4HB	P4HB encodes the beta subunit of prolyl 4-hydroxylase, part of the protein disulfide isomerase family. It functions in hydroxylation of prolyl residues in preprocollagen, disulfide bond rearrangement, and acts as a chaperone. P4HB also binds thyroid hormone, regulates S-nitrosothiol-bound nitric oxide, and is a component of the microsomal triglyceride transfer protein complex. It is implicated in breast cancer due to its multifunctional roles in protein folding and cellular processes.
RPS6	RPS6 encodes a ribosomal protein in the 40S subunit, part of the S6E family. It is phosphorylated by protein kinases in response to stimuli like growth factors. Phosphorylation affects cell growth and mRNA translation. RPS6 may influence proliferation and has pseudogenes across the genome, relevant to breast cancer studies.
CST3	CST3 encodes a cysteine protease inhibitor, part of type 2 cystatins, located on chromosome 20. It is abundant in biological fluids and expressed in most organs. Mutations link to amyloid angiopathy and reduced expression in aortic lesions connects it to vascular disease. It also inhibits herpes simplex virus replication. Alternative splicing produces multiple transcript variants.
FTH1	FTH1 encodes the heavy subunit of ferritin, an iron storage protein. Composed of 24 subunits, it affects iron uptake and release. Variants impact neurodegenerative diseases. FTH1 has pseudogenes and spliced transcript variants. Its role in breast cancer involves iron metabolism and cellular proliferation.
RPS4X	RPS4X encodes ribosomal protein S4, part of the 40S subunit in cytoplasmic ribosomes. It is one of two genes encoding this protein, the other being RPS4Y. Both isoforms are functionally equivalent. RPS4X is not subject to X-inactivation and may be linked to Turner syndrome. Multiple pseudogenes of RPS4X exist throughout the genome.
SSR4	SSR4 encodes the delta subunit of the translocon-associated protein complex, facilitating protein translocation across the endoplasmic reticulum membrane. Located in Xq28, it is arranged head-to-head with the IDH3G gene, sharing a CpG-embedded bidirectional promoter. Involved in breast cancer via protein translocation disruption. Multiple transcript variants exist due to alternate splicing.
RPL30	RPL30 encodes a ribosomal protein part of the 60S subunit, located in the cytoplasm. It co-transcribes with U72 snoRNA gene in its fourth intron. Multiple processed pseudogenes exist. RPL30's role in protein synthesis may intersect with breast cancer pathogenesis.
ERBB2	ERBB2 gene encodes an EGF receptor family member involved in signaling pathways like MAPK and PI3K. It forms heterodimers with other EGF receptors, influencing cancer progression. Amplification or overexpression is noted in breast and ovarian tumors. Isoform variations exist with alternative splicing leading to multiple transcripts.
APOE	APOE gene encodes a major apoprotein in chylomicrons, binding to liver and peripheral cell receptors. It is crucial for triglyceride-rich lipoprotein catabolism. Located on chromosome 19, it clusters with APOC1 and APOC2 genes. Mutations cause familial dysbetalipoproteinemia, affecting cholesterol and triglyceride clearance, linked to breast cancer risk.
AZGP1	AZGP1 is associated with cell adhesion, sensory perception of bitter taste, and extracellular space location. It is implicated in breast cancer and prostate carcinoma. It serves as a biomarker for diseases like gastrointestinal cancer, liver cirrhosis, lung adenocarcinoma, kidney failure, and obesity.
RPL3	RPL3 encodes a ribosomal protein in the 60S subunit, involved in protein synthesis. It binds HIV-1 TAR mRNA and may affect tat-mediated transactivation. Co-transcribed with small nucleolar RNA genes, it has splice variants and processed pseudogenes.
COX6C	Cytochrome c oxidase subunit VIc, part of mitochondrial respiratory chain, catalyzes electron transfer to oxygen. Encoded by nuclear gene, 77% identical to mouse VIc. Up-regulated in prostate cancer; implicated in breast cancer. Pseudogene located on chromosome 16p12. Functions in regulation and assembly of enzyme complex.
HLA-C	HLA-C gene encodes a class I molecule, consisting of a heavy chain and beta-2 microglobulin, crucial for immune system peptide presentation. The gene contains 8 exons, with polymorphisms in exons 2 and 3 affecting peptide binding specificity. HLA-C genetic variations influence immune responses and are typed for transplantation compatibility. In breast cancer, HLA-C polymorphisms may impact tumor immunity and patient outcomes. Over 6000 alleles are identified, affecting susceptibility to infections and disease outcomes.
FAU	FAU gene encodes a fusion protein with ubiquitin-like fubi and ribosomal protein S30, involved in ribosome function and antimicrobial activity. Fubi's role is unknown; S30 is part of the 40S ribosomal subunit. FAU is a homolog of the FBR-MuSV virus gene. Pseudogenes exist in the genome. Similar proteins include S27a and L40.
RPS9	RPS9 encodes a ribosomal protein part of the 40S subunit, located in the cytoplasm. It belongs to the S4P family. Variable expression observed in colorectal and breast cancer, with no correlation to disease severity. Multiple pseudogenes exist throughout the genome.
EEF2	EEF2 encodes a GTP-binding translation elongation factor essential for protein synthesis, facilitating GTP-dependent translocation of nascent polypeptides on ribosomes. Inactive upon EF-2 kinase phosphorylation, EEF2's activity is linked to cellular proliferation and may influence breast cancer development through its role in protein synthesis and cellular growth.
B2M	B2M encodes a serum protein associated with MHC class I on nucleated cells. It forms beta-pleated sheets and can become amyloid fibrils in pathology. B2M has antibacterial activity in amniotic fluid. Mutations may cause hypercatabolic hypoproteinemia. B2M is linked to breast cancer research.
RPS5	RPS5 encodes a ribosomal protein part of the 40S subunit, related to protein synthesis in the cytoplasm. It belongs to the S7P family. Variable expression has been noted in colorectal cancers. Multiple pseudogenes exist in the genome. Research may explore its role in breast cancer.
RPL12	RPL12 encodes a ribosomal protein part of the 60S subunit, binding to 26S rRNA, and belongs to the L11P family. Located in the cytoplasm, it is co-transcribed with U65 snoRNA in the fourth intron. Multiple processed pseudogenes are dispersed in the genome. RPL12 is associated with protein synthesis and its dysregulation may be linked to breast cancer.
ACTG1	ACTG1 encodes actin gamma 1, a cytoplasmic actin present in all cell types. Linked to cell motility and cytoskeletal maintenance, it influences breast cancer progression. Mutations are associated with DFNA20/26 hearing loss and Baraitser-Winter syndrome. Alternative splicing produces multiple transcript variants. Actins are key for cellular structure and function.
RPS27A	RPS27A encodes a fusion protein with ubiquitin and ribosomal protein S27a. Involved in protein degradation via the 26S proteasome. Ribosomal protein S27a is part of the 40S ribosomal subunit, has C4-type zinc finger domains, and is cytoplasmic. The gene has pseudogenes and alternative splicing variants. Related to breast cancer through involvement in translational control and cellular protein regulation.
RPL37	RPL37 encodes a ribosomal protein of the 60S subunit in the cytoplasm, part of the L37E family with a C2C2-type zinc finger-like motif. It has multiple pseudogenes in the genome. Associated with breast cancer in humans.
RPL23	RPL23 encodes a protein in the 60S ribosomal subunit, part of the L14P family. It is cytoplasmic and shares identity with yeast L17. Involved in protein synthesis, multiple pseudogenes exist. Linked to breast cancer through dysregulation affecting ribosome function and protein synthesis.
HLA-A	HLA-A, part of HLA class I molecules, is a heterodimer with heavy and light chains. It presents peptides to cytotoxic T cells, crucial for immune response. Expressed ubiquitously, it's involved in peptide binding via polymorphisms in exons 2 and 3. Essential for organ transplantation typing, HLA-A influences infectious disease outcomes, including HIV and SARS-CoV. Over 6000 alleles exist, affecting immune responses to viruses like SARS-CoV-2. Gene comprises 8 exons; exons 1-7 encode various domains and regions.
RPL31	RPL31 encodes a ribosomal protein in the 60S subunit, part of the L31E family, located in the cytoplasm. It shows higher expression in familial adenomatous polyps. Multiple pseudogenes are dispersed in the genome. Alternative splicing results in distinct isoforms. It may be involved in breast cancer through its role in protein synthesis regulation.
RPL29	RPL29 encodes a cytoplasmic ribosomal protein part of the 60S subunit, involved in protein synthesis. It belongs to the L29E family and binds heparin. Located at 3p21.3-p21.2, RPL29 has multiple pseudogenes. Its expression and function may impact breast cancer pathology.
RPL7A	RPL7A encodes a ribosomal protein part of the 60S subunit, involved in protein synthesis. It interacts with nuclear hormone receptors, inhibiting DNA binding. Located in surfeit gene cluster, co-transcribed with small nucleolar RNA genes. Rearranges with trk proto-oncogene to form chimeric oncogene trk-2h, linked to breast cancer. Multiple pseudogenes exist.
IFI27	IFI27 is linked to breast cancer, involved in defense response, ubiquitination, and inflammatory response. It influences transcription regulation and protein export, located in mitochondrial and nuclear membranes.
PABPC1	PABPC1 encodes a poly(A) binding protein involved in mRNA metabolism. It shuttles between the nucleus and cytoplasm, binds to the 3' poly(A) tail of mRNAs, promotes ribosome recruitment, translation initiation, and is required for poly(A) shortening, a step in mRNA decay. PABPC1 is linked to breast cancer and is part of a small gene family with related pseudogenes.
CD74	CD74 associates with MHC class II, regulates antigen presentation, acts as receptor for MIF, initiates survival pathways, promotes cell proliferation, interacts with APP, suppresses amyloid beta production. CD74 is linked to immune response and cell signaling, with multiple transcript variants.
BEST1	BEST1 encodes a bestrophin family protein involved in ion channel regulation. It forms chloride and bicarbonate ion channels, impacting epithelial and retinal cells. Mutations in BEST1 are linked to juvenile and adult-onset vitelliform macular dystrophy and other retinopathies. Its role in breast cancer is less clear but may involve ion channel regulation affecting cell proliferation and apoptosis.
RPL32	RPL32 encodes a ribosomal protein part of the 60S subunit in ribosomes, involved in protein synthesis. Located in the cytoplasm, it belongs to the L32E family. Mapped to 3p25-p24, it has multiple pseudogenes and alternatively spliced transcripts. Related to breast cancer.
FASN	FASN encodes a multifunctional enzyme that synthesizes palmitate from acetyl-CoA and malonyl-CoA using NADPH, producing long-chain saturated fatty acids. FASN is associated with breast cancer, where it can fuse with estrogen receptor-alpha (ER-alpha) in cancer cell lines. This fusion involves FAS's N-terminus and ER-alpha's C-terminus. FASN's activity is crucial in lipogenesis and may play a role in cancer development and progression.
S100A9	S100A9 encodes a protein in the S100 family with EF-hand calcium-binding motifs. It is found in the cytoplasm or nucleus, regulating cellular processes like cell cycle and differentiation. S100 genes cluster on chromosome 1q21. S100A9 inhibits casein kinase, shows altered expression in cystic fibrosis, and has antifungal and antibacterial activity. It is linked to breast cancer in humans.
GPX4	GPX4 encodes glutathione peroxidase, reducing hydrogen peroxide and lipid hydroperoxides, protecting cells from oxidative damage. It functions as a peroxidase and structural protein in sperm. Mutations linked to SMDS. GPX4 is a selenoprotein, requiring SECIS for selenocysteine incorporation. Transcript variants affect localization.
RPL15	RPL15 encodes a ribosomal protein in the 60S subunit. It is linked to breast cancer through elevated expression in various tumors. RPL15 is associated with Diamond-Blackfan anemia when deleted. The gene has multiple pseudogenes in the genome.
RPL27	RPL27 encodes a ribosomal protein of the L27e family within the 60S subunit, involved in protein synthesis. Mutations in RPL27 are linked to Diamond-Blackfan anemia and breast cancer. The gene has multiple pseudogenes dispersed in the genome.
MZT2B	MZT2B is associated with the cytosol, microtubule cytoskeleton, and nucleoplasm. It plays a role in the gamma-tubulin ring complex, which is crucial for microtubule nucleation. The gene may have implications in breast cancer pathways.
RPL23A	RPL23A encodes a 60S ribosomal subunit protein, part of the L23P family, located in the cytoplasm. It may mediate growth inhibition via interferon. Co-transcribed with small nucleolar RNAs within introns. Multiple pseudogenes exist. Potential involvement in breast cancer through ribosomal dysfunction affecting protein synthesis.
HSPB1	HSPB1 encodes a small heat shock protein involved in protein folding and stress response. It translocates to the nucleus under stress and aids cell differentiation. HSPB1 expression links to poor outcomes in various cancers, promoting proliferation and metastasis while inhibiting apoptosis. Mutations cause Charcot-Marie-Tooth disease and distal hereditary motor neuropathy.
MALAT1	MALAT1 produces a precursor transcript yielding a long non-coding RNA stabilized by a 3' triple helical structure, acting as a scaffold in the nucleus. It regulates transcription and cell cycle, influencing cancer metastasis and cell migration. Its upregulation is linked to tumor cell proliferation and metastasis in cancerous tissues.
RPS24	RPS24 encodes a cytoplasmic ribosomal protein in the 40S subunit, part of the S24E family. It plays a role in protein synthesis. Mutations can lead to Diamond-Blackfan anemia. It has multiple transcript variants and pseudogenes. Studies suggest a potential association with breast cancer.
COL1A1	COL1A1 encodes type I collagen pro-alpha1 chains, forming fibril collagen in connective tissues. Mutations link to osteogenesis imperfecta, Ehlers-Danlos syndromes, Caffey Disease, and osteoporosis. Translocations with chromosome 22 may cause dermatofibrosarcoma protuberans. Associated with breast cancer via extracellular matrix remodeling. Two transcripts exist.
C4B	C4B encodes complement factor 4, part of classical activation pathway, expressed as precursor cleaved into alpha, beta, gamma chains. Alpha chain releases C4 anaphylatoxin, involved in inflammation. Deficiency linked to lupus. Located in MHC class III on chromosome 6. Variants have 1-3 gene copies. Exists in long/short forms due to HERV-K retrovirus in intron 9. Possible role in breast cancer.
KRT18	KRT18 encodes type I intermediate filament keratin 18, partners with keratin 8 in epithelial tissues. Associated with cryptogenic cirrhosis. Mutations linked to cancer, including breast cancer. Two transcript variants exist.
CFL1	CFL1 encodes a protein that modulates actin polymerization and depolymerization, influenced by pH. It binds F-actin, inhibiting G-actin polymerization. Phosphorylation by LIM kinase assists actin cytoskeleton reorganization. CFL1 is implicated in actin-cofilin complex translocation from the cytoplasm to the nucleus, playing a role in cellular processes that can influence breast cancer progression.
CD81	CD81, a tetraspanin family member, is a cell-surface protein involved in signal transduction affecting cell development, activation, growth, motility, muscle cell fusion, and myotube maintenance. It complexes with integrins and is located in a tumor-suppressor gene region, making it a candidate for malignancies. Two transcript variants exist.
ALDOA	ALDOA encodes a glycolytic enzyme involved in fructose-1,6-bisphosphate conversion. It is part of the class I fructose-bisphosphate aldolase family and is linked to Glycogen Storage Disease XII. Its disruption contributes to various cancer progressions, including breast cancer. ALDOA has related pseudogenes on chromosomes 3 and 10.
RPL35A	RPL35A encodes a ribosomal protein in the 60S subunit, part of the L35AE family. Located at chromosome 3q29-qter, it binds tRNAs at ribosome's P site. Alternative splicing generates transcript variants, and pseudogenes exist throughout the genome. Involvement in breast cancer has been indicated.
SYNGR2	SYNGR2 encodes a membrane protein with four transmembrane regions and a phosphorylated cytoplasmic tail. It is part of the synaptogyrin gene family and may regulate membrane traffic in non-neuronal cells. Alternative splicing leads to multiple transcript variants. Its role in breast cancer involves cell signaling and membrane dynamics.
PPP1CA	PPP1CA encodes a catalytic subunit of protein phosphatase 1 (PP1), involved in serine/threonine dephosphorylation. It regulates cell division, glycogen metabolism, muscle contractility, protein synthesis, and HIV-1 transcription. Deregulation is linked to diabetes and cancers, including breast cancer. PPP1CA is broadly expressed with alternative splicing variants.
HLA-E	HLA-E is part of HLA class I heavy chain paralogues, forming heterodimers with beta-2 microglobulin. It binds peptides from leader peptides of other class I molecules. Its gene has 8 exons encoding leader peptide, alpha domains, transmembrane region, and cytoplasmic tail. HLA-E is implicated in immune response and may influence breast cancer progression.
TAGLN	TAGLN encodes an actin-binding protein of the calponin family. It is expressed in vascular and visceral smooth muscle and marks smooth muscle differentiation. The protein is linked to calcium-independent muscle contraction and acts as a tumor suppressor. Loss of TAGLN expression is associated with tumor development and cellular transformation.
RPL9	RPL9 encodes a ribosomal protein part of the 60S subunit involved in protein synthesis. It belongs to the L6P family and is found in the cytoplasm. The gene has multiple processed pseudogenes and alternative splicing produces various transcripts. RPL9 is associated with breast cancer studies.
CD63	CD63 is a tetraspanin family member involved in signal transduction, regulating cell development, activation, growth, and motility. It forms complexes with integrins and may act as a blood platelet activation marker. CD63 deficiency links to Hermansky-Pudlak syndrome and tumor progression. Alternative splicing produces multiple transcript variants.
RPS3A	RPS3A encodes a ribosomal protein in the 40S subunit, part of the S3AE family, located in the cytoplasm. It is co-transcribed with U73A and U73B small nucleolar RNA genes. Disruption in rats affects transformed phenotype. Multiple pseudogenes exist. Alternative splicing occurs. Associated with protein synthesis and linked to breast cancer in humans.
LGALS3BP	LGALS3BP encodes a beta-galactoside-binding protein involved in cell-cell and cell-matrix interactions. Elevated in cancer patients and HIV-infected individuals, it plays a role in immune response, impacting NK and LAK cell cytotoxicity. Localized to chromosome 17q25, it binds Mac-2 and galectin 1, relevant in breast cancer research.
IGFBP2	IGFBP2 encodes a protein binding IGF-I/IGF-II, involved in breast cancer progression. It exists as secreted and nonsecreted isoforms. High expression correlates with tumor growth and affects patient recovery. Transcript variants contribute to functional diversity. IGFBP2 interactions with ligands impact cellular processes related to cancer.
BST2	BST2 encodes bone marrow stromal cell antigen 2, implicated in pre-B-cell growth. It may influence rheumatoid arthritis and is linked to breast cancer progression through its role in immune response modulation and viral restriction.
TPT1	TPT1 encodes a protein regulating cellular growth and proliferation. Its mRNA contains a 5'-TOP tract, repressing translation in quiescence. The protein is involved in apoptosis, protein synthesis, cell division, stabilizes microtubules, and is removed via phosphorylation for mitotic progression. TPT1 is implicated in carcinogenesis, upregulated in some cancer cells, with alternative splicing leading to multiple isoforms.
EDF1	EDF1 gene encodes a protein involved in endothelial cell differentiation, lipid metabolism, and hormone-induced cardiomyocyte hypertrophy. It acts as a transcriptional coactivator linking TBP with gene-specific activators. Alternative splicing produces multiple transcripts. Research suggests potential roles in breast cancer modulation.
RPS25	RPS25 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. It belongs to the S25E family and is cytoplasmic. Multiple pseudogenes exist in the genome. RPS25 has been implicated in breast cancer, potentially influencing ribosome biogenesis and cellular proliferation.
ATP6V0B	Encodes V0 domain of vacuolar ATPase, essential for intracellular organelle acidification. Involved in protein sorting, zymogen activation, receptor-mediated endocytosis, synaptic vesicle proton gradient generation. Multiple transcript variants from alternative splicing. Associated with breast cancer in humans.
TAPBP	Encodes transmembrane glycoprotein mediating interaction between MHC class I and TAP for peptide transport across ER membrane. Essential for peptide loading on MHC class I. Contains C-terminal double-lysine motif for ER retention. Located in MHC on chromosome 6. Alternative splicing yields three isoforms. Linked to breast cancer.
GRINA	GRINA is involved in calcium channel activity, apoptotic signaling, negative regulation of apoptosis via death receptors, neuron apoptosis, endoplasmic reticulum calcium homeostasis, and stress-induced intrinsic apoptosis. Located in Golgi membrane, GRINA may impact breast cancer through apoptosis regulation and calcium homeostasis disruptions.
XBP1	XBP1 encodes a transcription factor regulating MHC class II genes, activated by ER stress via IRE1-mediated splicing. It produces isoforms XBP1(S) and XBP1(U), with XBP1(S) being functionally active. XBP1(U) negatively regulates XBP1(S) during ER stress recovery. XBP1 is linked to breast cancer through its role in protein folding and stress response pathways. A pseudogene exists on chromosome 5.
S100A11	S100A11 encodes a protein part of the S100 family, with 2 EF-hand calcium-binding motifs. Located in cytoplasm/nucleus, it's involved in cell cycle regulation, differentiation, motility, invasion, and tubulin polymerization. S100 genes cluster on chromosome 1q21. Altered expression relates to tumor metastasis, including breast cancer.
NBEAL1	NBEAL1 is associated with breast cancer. It enables protein kinase binding and is involved in protein localization. It is active in the cytosol and membrane.
AEBP1	AEBP1 encodes a carboxypeptidase A family protein, acts as a transcriptional repressor, involved in adipogenesis and smooth muscle cell differentiation, implicated in wound healing, abdominal wall development, glioblastoma, and breast cancer.
CCND1	CCND1 encodes a cyclin family protein, regulating CDK4/6 for cell cycle G1/S transition. Interacts with Rb tumor suppressor; expression regulated by Rb. Mutations, amplification, overexpression linked to altered cell cycle, common in breast cancer and various cancers.
OAZ1	OAZ1 encodes antizyme 1, regulating polyamine levels by inhibiting ornithine decarboxylase (ODC). This impacts cell growth, proliferation, and cancer pathways. Expression involves ribosomal frameshifting, influenced by polyamine levels. OAZ1 has broad tissue distribution and affects polyamine uptake. Alternative splicing and initiation sites lead to protein isoforms with distinct localizations.
RPL14	RPL14 encodes a ribosomal protein in the 60S subunit, part of the L14E family. It has a bZIP-like domain, is located in the cytoplasm, and features a polymorphic GCT repeat tract. This gene is linked to breast cancer. Multiple transcript variants exist, all encoding the same protein. Pseudogenes are dispersed throughout the genome.
TAGLN2	TAGLN2 encodes a protein similar to transgelin, an early marker in smooth muscle differentiation. Its specific function is undetermined, but it may act as a tumor suppressor. Multiple isoforms exist. TAGLN2 has been implicated in breast cancer research, suggesting a potential role in tumorigenesis.
FN1	FN1 encodes fibronectin, a glycoprotein in plasma and extracellular matrix, involved in cell adhesion, migration, embryogenesis, wound healing, blood coagulation, host defense, and metastasis. It undergoes alternative splicing producing various transcript variants. Fibronectin's role in metastasis links it to breast cancer progression.
PPDPF	PPDPF is involved in cell differentiation and TORC1 signaling, potentially influencing liver development. It is located in the mitochondrion and may have implications in breast cancer research.
BCAP31	BCAP31 encodes a transmembrane protein involved in transporting membrane proteins from the endoplasmic reticulum to the Golgi and caspase 8-mediated apoptosis. Microdeletions are linked to CADDS. Alternative splicing produces multiple transcript variants. Two pseudogenes are located on chromosome 16.
IFITM3	IFITM3 is part of the IFITM protein family, influencing viral entry restriction in cells. It is linked to breast cancer, potentially affecting immune responses and tumor progression. IFITM3 is associated with various viruses like influenza A, Ebola, and SARS-CoV-2.
PRDX1	PRDX1 encodes a peroxiredoxin family enzyme involved in reducing hydrogen peroxide and alkyl hydroperoxides. It supports antioxidant defense, influences CD8(+) T-cell antiviral activity, and affects cell proliferation. PRDX1 may play a role in cancer progression, including breast cancer. Four transcript variants exist for this gene.
BGN	BGN encodes a small leucine-rich proteoglycan involved in bone growth, muscle development, collagen fibril assembly, and may regulate inflammation and immunity. It might contribute to atherosclerosis and aortic valve stenosis and is related to gene decorin due to duplication. BGN's role in breast cancer is under study.
GNAS	GNAS exhibits imprinted expression with transcripts from alternative promoters and 5' exons, some with a differentially methylated region. It produces noncoding RNAs possibly regulating imprinting, and transcripts encoding the stimulatory G-protein alpha subunit involved in signal transduction. Mutations relate to pseudohypoparathyroidism, Albright hereditary osteodystrophy, McCune-Albright syndrome, and pituitary tumors. Associated with breast cancer.
PTMA	PTMA gene is associated with breast cancer in humans. It enables DNA-binding transcription factor binding and histone binding activities. The gene is involved in negative regulation of apoptotic processes and is located in the cytosol and nucleoplasm.
UBC	UBC encodes ubiquitin C, a polyubiquitin precursor involved in ubiquitination, impacting protein degradation, DNA repair, cell cycle regulation, kinase modification, endocytosis, and cell signaling pathways. Ubiquitination is linked to breast cancer via these cellular processes.
MZT2A	MZT2A is involved in breast cancer; localizes to centrosome, cytosol, and nucleoplasm. Plays a role in cell cycle regulation and centrosome function. Interacts with microtubules, potentially affecting mitotic spindle assembly. Research indicates potential implications in tumorigenesis pathways related to breast cancer.
SLC25A6	SLC25A6 is a mitochondrial carrier protein gene involved in ADP/ATP translocation across mitochondrial membranes, influencing apoptosis via the permeability transition pore complex. It's associated with breast cancer. Human genome contains non-transcribed pseudogenes related to it.
RPS20	RPS20 encodes a ribosomal protein part of the 40S subunit, related to protein synthesis. It belongs to the S10P family, located in the cytoplasm, and co-transcribed with U54 snoRNA. Multiple pseudogenes exist. Two transcript variants encode distinct isoforms. Mutations or dysregulation may be linked to breast cancer.
HSP90AB1	HSP90AB1 encodes a cytosolic heat shock protein involved in signal transduction, protein folding, degradation, and apoptosis. Alternative splicing produces multiple variants. Pseudogenes are present on several chromosomes. HSP90AB1 is implicated in breast cancer through its role in protein stabilization and cellular stress response.
RPS10	RPS10 encodes a ribosomal protein part of the 40S subunit, belonging to the S10E family, found in the cytoplasm. It shows variable expression in cancers, including breast cancer, without correlation to disease severity. Multiple processed pseudogenes and alternate splicing variants exist. Read-through transcription occurs with NUDT3.
MYL6	MYL6 encodes a myosin alkali light chain involved in muscle contraction. Expressed in smooth muscle and non-muscle tissues, it is part of a hexameric ATPase motor protein. MYL6 has pseudogenes and two transcript variants for different isoforms. Alterations in MYL6 may influence breast cancer progression through cell motility and signaling pathways.
CLDN3	CLDN3 encodes a claudin family protein, part of tight junction strands in epithelial/endothelial cells. It functions in cell adhesion, acts as a low-affinity receptor for Clostridium perfringens enterotoxin, and is associated with breast cancer. The gene is intronless and shares sequence similarity with an apoptosis-related protein in rats.
ATP6AP1	ATP6AP1 encodes a component of vacuolar ATPase (V-ATPase), essential for acidification of intracellular organelles. V-ATPase consists of a V1 catalytic domain and a V0 transmembrane domain, facilitating processes like protein sorting, zymogen activation, and receptor-mediated endocytosis. This gene may assist in neuroendocrine secretory granules' acidification and play a role in early development, potentially linked to breast cancer.
PRDX2	PRDX2 encodes a peroxiredoxin enzyme, reducing hydrogen peroxide and alkyl hydroperoxides, with roles in antioxidant protection and potential cancer progression. It stabilizes hemoglobin against oxidative stress, targeting hemolytic anemia. The protein's crystal structure is resolved at 2.7 angstroms. PRDX2 might influence CD8(+) T-cell antiviral activity. Pseudogenes are on chromosomes 5, 6, 10, and 13.
RPL24	RPL24 encodes a ribosomal protein part of the 60S subunit, involved in protein synthesis. Located in the cytoplasm, it belongs to the L24E family. The protein shares identity with L30 in S. cerevisiae. RPL24 has multiple pseudogenes. Studies indicate a potential role in breast cancer development, impacting ribosome function and cellular growth.
GNB2	GNB2 encodes a beta subunit of heterotrimeric G proteins, which regulate alpha subunits and signal transduction receptors. Involved in breast cancer, it contains a CCG repeat length polymorphism in the 5' UTR. G proteins integrate signals between receptors and effectors, composed of alpha, beta, and gamma subunits.
RPL34	RPL34 encodes a cytoplasmic ribosomal protein part of the 60S subunit, belonging to the L34E family. Located on chromosome 4q, its overexpression is linked to breast cancer. Alternative splicing generates multiple transcript variants, encoding the same isoform. Multiple pseudogenes exist in the genome.
RPL4	RPL4 encodes a cytoplasmic ribosomal protein, part of the 60S subunit, involved in protein synthesis. It belongs to the L4E ribosomal protein family and has multiple pseudogenes. RPL4 may be implicated in breast cancer due to its role in translation and cellular growth processes.
LMNA	LMNA encodes nuclear lamina proteins, affecting nuclear stability, chromatin structure, and gene expression. Mutations are linked to diseases including muscular dystrophies, lipodystrophy, cardiomyopathy, and progeria. It may also play a role in breast cancer, given its involvement in cellular structure and gene regulation.
NDUFA13	NDUFA13 encodes a subunit of mitochondrial NADH dehydrogenase (Complex I) involved in electron transfer. It interacts with STAT3 and may act as a tumor suppressor. The protein is approximately 16 kDa. Alternative transcripts exist but their function is unknown. NDUFA13 is linked to breast cancer due to its role in mitochondrial function and electron transport.
HLA-DRA	HLA-DRA is a class II alpha chain gene in the HLA complex, forming a heterodimer with a beta chain. It is expressed on antigen-presenting cells like B lymphocytes, dendritic cells, and macrophages, crucial for immune response by presenting pathogen peptides to T cells. The gene has 5 exons, with roles in encoding leader peptide, extracellular domains, transmembrane domain, and cytoplasmic tail. HLA-DRA acts as the alpha chain for DRB1, DRB3, DRB4, and DRB5 without polymorphisms in the peptide binding region.
SNHG25	SNHG25 is a non-coding RNA gene implicated in breast cancer. It is involved in the regulation of gene expression and may influence cancer cell proliferation and metastasis. SNHG25 interacts with various molecular pathways and factors contributing to cancer development. Further research is needed to elucidate its specific roles in breast cancer pathogenesis and potential as a therapeutic target.
TIMP1	TIMP1 gene, part of TIMP family, encodes proteins inhibiting matrix metalloproteinases (MMPs), involved in extracellular matrix degradation. Besides inhibiting MMPs, it promotes cell proliferation and may have anti-apoptotic functions. Gene transcription is inducible by cytokines and hormones, and its inactivation is polymorphic in females. Located in intron 6 of synapsin I, transcribed oppositely. Associated with breast cancer pathogenesis.
H1-10	H1-10 encodes a replication-independent histone, part of the H1 family, involved in chromatin structure. Histones are nuclear proteins, forming nucleosomes with DNA, aiding chromatin compaction. H1 interacts with DNA between nucleosomes. Alterations in histone genes, including H1-10, may influence cancer development, like breast cancer, through changes in chromatin dynamics affecting gene expression regulation.
RPS23	RPS23 encodes a ribosomal protein in the 40S subunit, part of the S12P family, located in the cytoplasm. It shares amino acid similarity with yeast protein S28. Linked to breast cancer due to its role in protein synthesis regulation. Multiple pseudogenes exist throughout the human genome.
COX8A	COX8A encodes a nuclear-encoded subunit of cytochrome c oxidase, the terminal enzyme in the mitochondrial respiratory chain. It facilitates electron transfer from cytochrome c to oxygen, contributing to the proton gradient generation across the inner mitochondrial membrane. COX8A is implicated in mitochondrial function and possibly in breast cancer pathology through its role in energy metabolism and cellular respiration.
KRT8	KRT8 encodes a type II keratin, part of intermediate filaments in epithelial cells, functioning in structural integrity, signal transduction, and differentiation. Mutations linked to cryptogenic cirrhosis. Located on chromosome 12, KRT8 forms filaments with keratin 18. Involved in breast cancer pathology.
LY6E	Encodes a GPI-anchored protein in the Ly6 family, involved in T cell physiology, oncogenesis, immunological regulation, and viral infection modulation, including SARS-CoV, MERS-CoV, SARS-CoV-2. Related to breast cancer.
ENO1	ENO1 encodes alpha-enolase, a glycolytic enzyme and structural lens protein in its monomeric form. It forms homodimers and has a tumor suppressor role when binding to the c-myc promoter. It is involved in breast cancer as a potential biomarker. ENO1 also acts as an autoantigen in Hashimoto encephalopathy. Pseudogenes are located on chromosome 1.
GRN	GRN encodes the progranulin protein, precursor to granulins, involved in cell growth regulation. Granulins, cleaved into peptides like granulin A and B, modulate growth as inhibitors or stimulators. GRN is implicated in development, wound healing, and tumorigenesis, including breast cancer. The gene's role in breast cancer is linked to its influence on cell proliferation and tumor progression.
PTPRF	PTPRF encodes a receptor-type protein tyrosine phosphatase involved in cell signaling, regulating growth, differentiation, mitotic cycle, and oncogenic transformation. It has extracellular, transmembrane, and intracytoplasmic regions, influencing epithelial cell junctions and beta-catenin signaling. Associated with insulin resistance, PTPRF has two transcript variants. Linked to breast cancer, it may affect tumor progression via cell adhesion and signaling pathways.
RPL7	RPL7 encodes a ribosomal protein in the 60S subunit, involved in protein synthesis regulation. It has BZIP-like domain mediating DNA/RNA binding and affects mRNA translation. Located in cytoplasm, it acts as autoantigen in systemic autoimmune diseases. Associated with breast cancer, multiple pseudogenes exist.
UBB	UBB encodes ubiquitin, involved in protein degradation, chromatin structure, gene regulation, and stress response. It forms polyubiquitin chains or single moieties. Aberrant forms are linked to Alzheimer's and Down syndrome. Pseudogenes are on chromosomes 1, 2, 13, 17. Alternative splicing produces multiple transcripts. In breast cancer, ubiquitin pathways may affect protein stability and tumor progression.
BSG	BSG encodes basigin, a plasma membrane protein in the immunoglobulin superfamily, involved in spermatogenesis, embryo implantation, neural network formation, and tumor progression. It is expressed in various tissues and has multiple transcript variants. Basigin's role in tumor progression links it to breast cancer studies.
ELOB	ELOB encodes elongin B, part of the transcription factor SIII complex. It regulates transcription elongation with elongin A and C, suppressing RNA polymerase II pausing. Elongin A2 is testis-specific. ELOB interacts with the von Hippel-Lindau tumor suppressor, affecting transcription. Two isoforms exist. Pseudogenes are on chromosomes 11 and 13. Linked to breast cancer.
COX6B1	COX6B1 encodes subunit VIb of cytochrome c oxidase, part of the mitochondrial respiratory chain. This gene is nuclear-encoded and may regulate assembly. Mutations link to infantile encephalomyopathy. Related to breast cancer in humans, COX6B1 includes pseudogenes on chromosomes 7, 17, and 22q13.1-13.2.
TMSB4X	TMSB4X encodes an actin-sequestering protein involved in actin polymerization, cell proliferation, migration, and differentiation. It escapes X inactivation and has a homolog on chromosome Y. Associated with breast cancer, it influences tumor progression and metastasis.
C1QA	C1QA encodes the A-chain of serum complement C1q, involved in the complement system. C1q, with C1r and C1s, forms the first component. Deficiency links to lupus and glomerulonephritis. C1q has 18 chains: 6 A, 6 B, 6 C. Chains feature N-terminal collagen-like and C-terminal globular domains. Alternative splicing creates multiple transcripts. Related to breast cancer through immune system pathways.
PRSS8	PRSS8 encodes a serine protease in the peptidase S1 family. It is expressed in prostate epithelia and seminal fluid, cleaving protein substrates at lysine or arginine residues. PRSS8 mediates activation of the epithelial sodium channel, affecting sodium balance and epithelial barrier formation. It is linked to breast cancer through protease activity affecting cellular environments.
RPL5	RPL5 encodes a ribosomal protein in the 60S subunit, binding 5S rRNA for ribosome assembly. It may inhibit tumorigenesis by activating tumor suppressors and reducing oncoprotein expression. Mutations are linked to Diamond-Blackfan Anemia. RPL5 co-transcribes with small nucleolar RNA U21; multiple pseudogenes exist. Related to breast cancer through ribosome function affecting cell growth regulation.
UQCR11	UQCR11 encodes a component of the ubiquinol-cytochrome c reductase complex in the mitochondrial respiratory chain, potentially serving as a binding factor for the iron-sulfur protein. Its role is implicated in breast cancer through mitochondrial dysfunction and oxidative stress, influencing cancer cell metabolism and growth.
RPS7	RPS7 encodes a ribosomal protein of the 40S subunit, part of the S7E family. It is cytoplasmic and linked to ribosome function. RPS7 has multiple pseudogenes across the genome. Studies indicate a potential association with breast cancer, possibly influencing protein synthesis regulation and cellular growth processes.
A2M	A2M encodes a protease inhibitor and cytokine transporter involved in protease inhibition and cytokine regulation. It affects breast cancer through inflammatory pathway disruptions. A2M mutations cause alpha-2-macroglobulin deficiency and are linked to Alzheimer's disease by mediating A-beta clearance. Located on chromosome 12, A2M has a related pseudogene.
RPS15A	RPS15A encodes a ribosomal protein of the 40S subunit, part of the S8P family, located in the cytoplasm. It is involved in protein synthesis. The gene has multiple pseudogenes across the genome. RPS15A is associated with breast cancer in humans.
VIM	VIM encodes a type III intermediate filament protein, part of the cytoskeleton, maintaining cell shape and cytoplasm integrity. It stabilizes cytoskeletal interactions and is involved in neuritogenesis, cholesterol transport, cell attachment, migration, and signaling. Pathogens attach to it on host cells. Mutations link to congenital cataracts. Related to breast cancer.
S100A6	S100A6 is a member of the S100 protein family with EF-hand calcium-binding motifs. It is involved in cellular processes like cell cycle progression, differentiation, Ca2+-dependent insulin release, prolactin secretion, and exocytosis. S100A6 genes are clustered on 1q21. Chromosomal rearrangements and altered expression are linked to melanoma. Research suggests potential involvement in breast cancer due to similar pathways and cellular mechanisms.
NDUFA11	NDUFA11 encodes a subunit of mitochondrial complex I, part of the electron transport chain. Mutations in NDUFA11 are linked to mitochondrial complex I deficiency. This gene's dysfunction may contribute to altered cellular metabolism in breast cancer. Alternate splicing produces multiple transcript variants.
PSMD3	PSMD3 encodes a non-ATPase subunit of the 19S regulator lid of the 26S proteasome, which is involved in ATP/ubiquitin-dependent peptide cleavage. It is associated with breast cancer susceptibility and influences neutrophil count through single nucleotide polymorphisms.
EVL	EVL gene encodes a protein involved in SH3 domain and profilin binding. It plays roles in negative regulation of epithelial cell migration and ruffle assembly, and positive regulation of stress fiber assembly. Located in the membrane, EVL is associated with processes relevant to breast cancer pathology.
APOC1	APOC1, located on chromosome 19, encodes apolipoprotein C1, involved in HDL and VLDL metabolism. Expressed in liver, activated in macrophage differentiation, inhibits cholesteryl ester transfer protein. Associated with breast cancer risk through lipid metabolism pathways. Pseudogene nearby; multiple transcript variants via alternative splicing and promoters.
H3-3B	H3-3B encodes a replication-independent histone H3, part of nucleosome structure in chromosomal fiber. It differs from typical histone genes by containing introns and polyadenylated mRNA. Histone variants like H3-3B have roles in chromatin dynamics and gene regulation, which may impact breast cancer progression.
ATP5F1E	ATP5F1E encodes the epsilon subunit of mitochondrial ATP synthase's catalytic core, involved in ATP synthesis via oxidative phosphorylation. It includes two pseudogenes on chromosomes 4 and 13, and read-through transcripts with SLMO2 gene exons. This gene's dysfunction may affect energy production, implicated in breast cancer.
PLXNB2	PLXNB2 encodes a transmembrane receptor involved in axon guidance and cell migration. It responds to semaphorins, contributing to signaling pathways potentially linked to breast cancer pathogenesis in humans.
MYL9	MYL9 encodes a myosin light chain involved in muscle contraction regulation. It modulates ATPase activity of myosin heads, binds calcium, and is activated by myosin light chain kinase. MYL9 has two transcript variants encoding different isoforms. In breast cancer, MYL9 is implicated in cell motility and invasion processes.
TUBA1B	TUBA1B is involved in breast cancer; functions include GTP binding, GTPase activity, ubiquitin protein ligase binding; structural role in cytoskeleton; participates in microtubule organization; active in microtubule cytoskeleton.
CTSB	CTSB encodes a C1 family lysosomal cysteine protease with endopeptidase and exopeptidase activity. It processes amyloid precursor protein (APP) and is linked to Alzheimer's disease. Overexpression is associated with esophageal adenocarcinoma and tumors, including breast cancer. CTSB also cleaves SARS-CoV-2 spike protein. Multiple transcript variants and pseudogenes exist.
ISG15	ISG15 is a ubiquitin-like protein involved in protein conjugation upon interferon activation, affecting chemotaxis, cell signaling, and antiviral activity. It influences target protein direction to intermediate filaments and can be secreted. Its role in breast cancer includes modulating immune response and protein stability, impacting tumor progression and therapy response.
FLNA	FLNA encodes an actin-binding protein involved in cytoskeletal remodeling, affecting cell shape and migration. It interacts with integrins, receptor complexes, and messengers. Mutations cause syndromes like PVNH1, OPD1, FMD, MNS, CIIPX. Two isoforms exist. FLNA's role in breast cancer involves cytoskeletal dynamics influencing tumor cell movement and invasion, impacting metastasis. Altered FLNA expression correlates with tumor progression, serving as a potential biomarker and therapeutic target in breast cancer research.
RPS13	RPS13 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. It belongs to the S15P family, located in the cytoplasm, and binds 5.8S rRNA. The E. coli ortholog aids early ribosome assembly. Co-transcribed with U14 snoRNA genes, it has multiple pseudogenes scattered in the genome. Associated with breast cancer.
NDUFB9	NDUFB9 encodes a subunit of mitochondrial oxidative phosphorylation complex I, involved in electron transport and NADH dehydrogenation. Complex I deficiency is linked to disorders like hypertrophic cardiomyopathy and neurodegenerative diseases. Pseudogenes are present on chromosomes 5, 7, and 8. Alternative splicing results in multiple transcript variants. This gene is associated with breast cancer in humans.
EIF4A1	EIF4A1 facilitates double-stranded RNA binding and translation initiation. It plays a role in cytoplasmic translational initiation and transcription regulation by RNA polymerase II. It is found in nuclear stress granules, perinuclear cytoplasm, and the plasma membrane. Associated with breast cancer, its dysregulation can impact oncogenic signaling pathways and cellular proliferation.
POLR2L	POLR2L encodes a subunit of RNA polymerase II, crucial for mRNA synthesis in eukaryotes, featuring an atypical zinc-binding domain. It may be shared with other DNA-directed RNA polymerases. Involved in transcription regulation, alterations in POLR2L are associated with breast cancer pathogenesis.
CYBA	CYBA encodes the light, alpha subunit of cytochrome b, part of the microbicidal oxidase system in phagocytes. Mutations can lead to chronic granulomatous disease (CGD), affecting superoxide generation crucial for microbicidal activity. Implicated in breast cancer research due to its role in cellular oxidative processes.
CRIP2	CRIP2 encodes a transcription factor with LIM zinc-binding domains. It may be involved in smooth muscle differentiation and has multiple transcript variants. CRIP2 is associated with breast cancer in humans.
EEF1D	EEF1D encodes a subunit of the elongation factor-1 complex, acting as a guanine nucleotide exchange factor. It interacts with HIV-1 Tat, repressing host protein translation and enhancing viral protein translation. It has multiple transcript variants and pseudogenes on chromosomes 1, 6, 7, 9, 11, 13, 17, 19. Associated with breast cancer in humans.
ATP1A1	ATP1A1 encodes an alpha 1 subunit of Na+/K+ -ATPase, a P-type cation transport ATPase. It maintains Na and K ion gradients across the plasma membrane, crucial for osmoregulation, sodium-coupled transport, and electrical excitability. The enzyme includes a large catalytic and a smaller glycoprotein subunit. ATP1A1 has multiple transcript variants encoding isoforms. Its role in breast cancer involves ion gradient disruption affecting cell viability and proliferation.
ELF3	ELF3 is a gene encoding a transcription factor that binds DNA, influencing RNA polymerase II activity. It plays roles in transcription regulation, inflammatory response, and is located in the Golgi apparatus, cytosol, and nucleoplasm. ELF3 is associated with breast cancer, affecting cell proliferation and differentiation.
TUFM	TUFM encodes a mitochondrial protein involved in translation. Mutations link to oxidative phosphorylation deficiencies, lactic acidosis, and fatal encephalopathy. Chromosome 17 has a pseudogene. Studies suggest a role in breast cancer due to mitochondrial dysfunction and altered energy metabolism.
SH3BGRL3	SH3BGRL3 is involved in cytoskeleton organization and is located in the cytosol, nuclear body, and ruffle membrane. It has been associated with breast cancer in humans.
STARD10	STARD10 is involved in lipid binding and transport, affects bile acid secretion, and regulates the peroxisome proliferator-activated receptor signaling pathway. Located in the cytosol, it is associated with breast cancer in humans.
C3	C3 is central to complement system activation, vital for classical and alternative pathways. It generates alpha and beta subunits, forming mature protein and several peptides. C3a peptide modulates inflammation and has antimicrobial activity. Mutations are linked to atypical hemolytic uremic syndrome, age-related macular degeneration, and potentially breast cancer.
GUK1	GUK1 encodes an enzyme that transfers a phosphate group from ATP to GMP, forming GDP. It is a target for cancer chemotherapy. Multiple transcript variants encoding different isoforms exist. In breast cancer studies, altered GUK1 expression may affect tumor cell growth and proliferation.
ZNF90	ZNF90 is associated with DNA-binding transcription factor activity, related to RNA polymerase II. It plays a role in the regulation of DNA-templated transcription and is located in the nucleus. This gene may have implications in breast cancer due to its regulatory functions.
C12orf57	C12orf57 is ubiquitously expressed in human tissues, essential for corpus callosum development. Mutations link to Temtamy syndrome. Involvement in breast cancer requires further exploration. Multiple transcript variants exist.
TLE5	TLE5 is part of the groucho/TLE protein family, linked to neurogenesis and gene repression. It forms homo- or heterooligomers, affecting expression of family genes. TLE5 has three transcript variants and is studied in breast cancer research for its role in cellular development and gene regulation.
SEC61A1	SEC61A1 encodes an alpha subunit of the SEC61 complex, involved in polypeptide insertion into the endoplasmic reticulum. It associates with ribosomes. SEC61 complex includes alpha, beta, and gamma subunits. Related to breast cancer through its role in protein synthesis and cellular transport processes.
SDC1	SDC1 encodes a transmembrane heparan sulfate proteoglycan in the syndecan family. It mediates cell binding, signaling, cytoskeletal organization, and internalizes HIV-1 tat protein. Functions include cell proliferation, migration, and cell-matrix interactions. Altered expression is observed in various tumors, including breast cancer. Two major transcript variants exist, encoding the same protein.
PLD3	PLD3 encodes a phospholipase D family enzyme involved in membrane phospholipid hydrolysis. It affects amyloid-beta precursor protein processing. Mutations are linked to Alzheimer disease risk. Alternative splicing occurs, producing the same protein. Its role in breast cancer is under investigation.
SPDEF	SPDEF, a member of the ETS transcription factor family, is linked to breast cancer. It acts as an androgen-independent transactivator of prostate-specific antigen (PSA) promoter. SPDEF expression is higher in breast, brain, lung, and ovarian tumors compared to normal tissues. It is a potential target for specific cancer therapies. Multiple isoforms exist due to alternative splicing.
ARHGDIA	ARHGDIA encodes a protein regulating Rho GTPases signaling, inhibiting Rho family GDP dissociation, keeping them inactive. It impacts cellular processes and may alter expression in tumors. Mutations link to nephrotic syndrome type 8. Alternate splicing creates multiple transcripts. Related to breast cancer.
IFI6	IFI6, induced by interferon, regulates apoptosis. It has a minisatellite with 26 repeats near exon 2's end, resembling splice donor sequences. Alternately spliced variants encode isoforms using downstream repeat sites. Associated with breast cancer.
LAPTM5	LAPTM5 encodes a transmembrane receptor linked to lysosomes; involved in hematopoiesis. Research suggests potential association with breast cancer mechanisms, likely affecting cellular transport and signaling pathways.
RPL41	RPL41 is involved in cytoplasmic translation and enables mRNA 3'-UTR and 5'-UTR binding activities. It is located in the endoplasmic reticulum and is part of the cytosolic large ribosomal subunit. Associated with breast cancer in humans.
CLU	CLU encodes a secreted chaperone protein involved in cell death, tumor progression, and neurodegenerative disorders. It is associated with breast cancer and found in the cytosol under stress. Alternate splicing results in coding and non-coding variants.
GNAI2	GNAI2 encodes an alpha subunit of G proteins, involved in hormonal regulation of adenylate cyclase. It has variations encoding different isoforms. Linked to cellular signaling pathways, it may play a role in breast cancer development.
PFDN5	PFDN5 encodes a prefoldin alpha subunit, part of a chaperone complex aiding polypeptide folding. It comprises two alpha and four beta subunits forming a beta barrel with coiled-coils. PFDN5 may repress proto-oncogene c-Myc activity, impacting breast cancer. Alternative splicing results in different isoforms, affecting its function.
RPL39	RPL39 encodes a ribosomal protein part of the 60S subunit, involved in protein synthesis. Located in the cytoplasm, it is co-transcribed with U69 snoRNA. Its role in breast cancer relates to its impact on ribosomal function and protein synthesis regulation. Multiple pseudogenes exist in the genome.
SSR2	SSR2 is a subunit of the signal sequence receptor involved in protein translocation across the ER membrane. It is a 22-kD glycoprotein located on chromosome bands 1q21-q23. Research indicates potential association with breast cancer, implicating its role in cellular processes.
COX4I1	COX4I1 encodes a nuclear-encoded subunit IV isoform 1 of cytochrome c oxidase, part of the mitochondrial respiratory chain. It facilitates electron transfer from cytochrome c to oxygen, contributing to a proton gradient. Located near NOC4, it shares a promoter. Pseudogenes exist on chromosomes 13 and 14. Alternative splicing yields multiple isoforms. Associated with breast cancer.
RHOC	RHOC encodes a Rho family GTPase involved in actin cytoskeleton reorganization, regulating cell shape, attachment, motility, and locomotion. It cycles between GDP-bound inactive and GTP-bound active states. Localized in the cytoplasm and plasma membrane, its overexpression links to tumor cell proliferation and metastasis in breast cancer. Multiple spliced variants exist, encoding the same protein.
JUP	JUP encodes a cytoplasmic protein found in desmosomes and intermediate junctions. It interacts with cadherins and is part of the catenin family, featuring armadillo repeats. Mutations link to Naxos disease and breast cancer. Alternative splicing occurs, but not all transcripts are described.
EIF4G1	EIF4G1 encodes a component of the EIF4F complex, crucial for mRNA recruitment to ribosomes. It facilitates mRNA cap recognition and ATP-dependent unwinding of secondary structures. The protein acts as a scaffold, binding other EIF4F members. Its N-terminus interacts with poly(A)-binding protein, aiding mRNA circularization in translation. Alternative splicing and promoter usage yield multiple transcripts. Linked to breast cancer.
FXYD3	FXYD3 encodes a membrane protein in the FXYD-domain family, involved in regulating Na+/K+ ATPases. It plays a role in ion-pump and ion-channel function and may contribute to tumor progression, including breast cancer. Alternative splicing produces multiple isoforms. Variants impact cellular processes relevant to cancer biology.
TSPO	TSPO encodes a mitochondrial protein involved in cholesterol transport for steroid hormone synthesis. It interacts with benzodiazepines, showing different affinities than its endogenous counterpart. Alternative splicing results in variants, with one being non-coding. TSPO is implicated in breast cancer due to its role in cell proliferation and apoptosis regulation.
UQCRQ	UQCRQ encodes a ubiquinone-binding protein involved in mitochondrial respiratory chain complex III, crucial for electron transport. Mutations may affect cellular respiration, potentially influencing breast cancer development.
COL1A2	Encodes pro-alpha2 chain of type I collagen, found in connective tissues, bone, cornea, dermis, tendon. Related to osteogenesis imperfecta, Ehlers-Danlos syndrome, osteoporosis, Marfan syndrome. Involves matrix integrity. Less severe mutations compared to COL1A1. Three transcripts identified. Associated with breast cancer.
RPL10A	RPL10A encodes a ribosomal protein in the 60S subunit, part of the L1P family, located in the cytoplasm. Downregulated by cyclosporin-A in the thymus and in neural precursor cells during development. Formerly known as NEDD6. Associated with breast cancer, with multiple pseudogenes in the genome.
S100A8	S100A8 is a member of the S100 protein family, containing EF-hand calcium-binding motifs. It is involved in cellular processes, including cell cycle regulation and differentiation. Located on chromosome 1q21, this gene may inhibit casein kinase and act as a cytokine. Altered expression is linked to cystic fibrosis and breast cancer. There are multiple transcript variants encoding different isoforms.
SELENOW	SELENOW encodes a selenoprotein with a selenocysteine residue, using UGA codon for Sec insertion. It features a SECIS element in 3' UTRs for UGA recognition. Expressed in muscle, heart, and brain, it belongs to SelWTH family with thioredoxin-like fold and CxxU motif, indicating redox function. In mice, it aids muscle growth and neuron protection from oxidative stress. A pseudogene exists on chromosome 1.
TPI1	TPI1 encodes an enzyme for G3P and DHAP isomerization in glycolysis and gluconeogenesis. Mutations cause triosephosphate isomerase deficiency. Pseudogenes on chromosomes 1, 4, 6, 7. Alternative splicing creates multiple transcripts. Implicated in breast cancer.
ATP5MC2	ATP5MC2 encodes a subunit of mitochondrial ATP synthase involved in ATP synthesis during oxidative phosphorylation. This gene is one of three encoding subunit c of the proton channel, with multiple pseudogenes. ATP5MC2 may have implications in breast cancer through its role in cellular energy production and regulation.
PTMS	PTMS gene associated with breast cancer. Involved in histone binding, negative regulation of apoptosis, and transcription regulation via RNA polymerase II. Functions in nucleus. Potential role in breast cancer progression or suppression.
IGFBP5	IGFBP5 binds IGF-I, regulates cell migration, proliferation, involved in cAMP response, forms ternary complex, linked to breast cancer progression, biomarker for pulmonary fibrosis.
LGALS1	LGALS1 encodes a beta-galactoside-binding protein involved in cell-cell and cell-matrix interactions. It may function as an autocrine factor regulating cell proliferation. LGALS1 is associated with breast cancer through modulation of tumor progression and metastasis.
SPINT2	SPINT2 encodes a transmembrane protein with extracellular Kunitz domains that inhibit serine proteases, including HGF activator. It acts as a tumor suppressor, linked to breast cancer and mutations lead to congenital sodium diarrhea. Multiple transcript variants exist.
RPSA	RPSA encodes the non-integrin laminin receptor 1 involved in cell adhesion, differentiation, and metastasis. It is linked to breast cancer through its role in cell surface interactions and has higher expression in cancerous tissues. Known as 67 kD laminin receptor, 37 kD laminin receptor precursor, and p40 ribosome-associated protein. Multiple pseudogenes exist, likely from retroposition. Two alternatively spliced transcripts encode the same protein.
GSTP1	GSTP1 is a polymorphic gene encoding variant proteins in the GST enzyme family, involved in detoxification, xenobiotic metabolism, and cancer susceptibility, particularly breast cancer. GSTs conjugate compounds with glutathione, categorized into alpha, mu, pi, and theta classes. GSTP1 variants are linked to functional differences in enzyme activity, affecting individual cancer risk.
CHCHD2	CHCHD2 encodes a CX(9)C protein involved in electron transport and apoptosis regulation. It translocates from mitochondria to nucleus under stress, activating oxygen responsive elements. CHCHD2 decreases in mitochondria during apoptosis, allowing BCL2-associated X protein activation. It has pseudogenes on multiple chromosomes and alternative splicing yields various transcripts.
EIF5A	EIF5A enables U6 snRNA binding, involved in cellular response to virus, regulation of apoptotic signaling, and tumor necrosis factor signaling. Located in annulate lamellae, cytoplasm, nucleus; part of nuclear pore. Biomarker of colorectal cancer and linked to breast cancer.
COX5B	COX5B is a nuclear-encoded subunit of cytochrome c oxidase (COX), involved in the mitochondrial respiratory chain. COX transfers electrons from cytochrome c to oxygen, contributing to proton gradient formation across the inner mitochondrial membrane. COX consists of 13 subunits, with electron transfer and proton pumping by mitochondrial-encoded subunits. COX5B's role in the regulation and assembly of COX complex is unclear. Linked to breast cancer.
ATG10	ATG10 is an E2-like enzyme involved in autophagy, crucial for autophagosome formation. It facilitates ATG12-ATG5 conjugation and MAP-LC3 modification, converting MAP1LC3A to its membrane-bound form, impacting breast cancer pathways.
RPL6	RPL6 encodes a component of the 60S ribosomal subunit. It binds to domain C of the tax-responsive enhancer element of HTLV-1, potentially participating in tax-mediated transcription transactivation. Multiple processed pseudogenes exist in the genome. Alternative splicing leads to various transcript variants. RPL6 has been linked to breast cancer development through its role in protein synthesis and cell growth regulation.
EEF1A1	EEF1A1 encodes alpha subunit of elongation factor-1 complex, delivering aminoacyl tRNAs to ribosome. Expressed in brain, placenta, lung, liver, kidney, pancreas. Isoform alpha 1 linked to Felty syndrome autoantigen. Multiple chromosome copies, some pseudogenes. Related to breast cancer, potentially affecting protein synthesis regulation or cellular proliferation.
CAPNS1	CAPNS1 encodes the regulatory subunit of calpain heterodimers, affecting cellular functions like apoptosis and proliferation. It is linked to calcium-dependent cysteine proteinases in mammalian cells. Associated with neurodegenerative diseases, CAPNS1 may influence breast cancer progression. A pseudogene exists on chromosome 1. Alternative splicing results in various transcripts.
LMAN2	LMAN2 encodes a type I transmembrane lectin involved in glycoprotein sorting, trafficking, and quality control. It shuttles between the endoplasmic reticulum, Golgi apparatus, and plasma membrane, binding high mannose glycoproteins. Research indicates potential associations with breast cancer through its role in cell membrane dynamics.
UBE2M	UBE2M encodes an E2 ubiquitin-conjugating enzyme involved in protein ubiquitination and degradation. It interacts with NEDD8, conjugating to proteins like Cdc53/culin. UBE2M's function is related to breast cancer mechanisms in humans.
SPARC	SPARC encodes a cysteine-rich acidic matrix-associated protein involved in collagen calcification in bone, extracellular matrix synthesis, and cell shape changes. Associated with tumor suppression and metastasis, influencing tumor cell invasion. Three transcript variants encoding isoforms exist.
EIF3C	EIF3C is part of the eukaryotic translation initiation factor 3 complex, enabling ribosome binding and contributing to translation initiation. It is involved in positive regulation of translation and translational initiation. Associated with breast cancer, EIF3C may influence tumor progression through altered protein synthesis pathways.
GAS5	GAS5 encodes a long non-coding RNA involved in regulating glucocorticoid receptor activity by mimicking GRE. It hosts C/D box snoRNA genes and influences androgen, progesterone, and mineralocorticoid receptors. GAS5 is linked to cellular growth arrest, apoptosis, and acts as a tumor suppressor, with down-regulation associated with breast cancer and other tissues.
TUBB	TUBB encodes beta tubulin, forming dimers with alpha tubulin for microtubule structure. Mutations link to cortical dysplasia, complex brain malformations. Alternative splicing yields variants. Pseudogenes located on chromosomes 1, 6, 7, 8, 9, 13. Associated with breast cancer.
ACTN4	ACTN4 encodes a nonmuscle alpha actinin involved in actin binding. It is part of the spectrin superfamily, located in the cytoplasm, and linked to metastatic processes in cancer. Mutations are associated with focal segmental glomerulosclerosis. In breast cancer, ACTN4 may influence cell motility and invasiveness, contributing to cancer progression.
IGFBP4	IGFBP4 encodes a protein in the IGFBP family, with IGFBP and thyroglobulin type-I domains. It binds IGF I and II, affecting their plasma half-life and receptor interactions. In breast cancer, IGFBP4 may modulate cell growth and apoptosis via IGF pathways.
